Omalizumab as a premedication in venom immunotherapy: When is it indicated in systemic mastocytosis?
Author
Buyukozturk, S.
Yegit, O. O.
Unal, D.
Colakoglu, B.
Demir, S.
Gelincik, A.
Metadata
Show full item recordCollections
- Bildiri [64839]